Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2024 Jan 3:2024.01.03.574055.
doi: 10.1101/2024.01.03.574055.

VLP-Based Model for Study of Airborne Viral Pathogens

Affiliations

VLP-Based Model for Study of Airborne Viral Pathogens

Michael Caffrey et al. bioRxiv. .

Update in

Abstract

The recent COVID-19 pandemic has underscored the danger of airborne viral pathogens. The lack of model systems to study airborne pathogens limits the understanding of airborne pathogen distribution, as well as potential surveillance and mitigation strategies. In this work, we develop a novel model system to study airborne pathogens using virus like particles (VLP). Specifically, we demonstrate the ability to aerosolize VLP and detect and quantify aerosolized VLP RNA by Reverse Transcription-Loop-Mediated Isothermal Amplification (RT-LAMP) in real-time fluorescent and colorimetric assays. Importantly, the VLP model presents many advantages for the study of airborne viral pathogens: (i) similarity in size and surface components; (ii) ease of generation and noninfectious nature enabling study of BSL3 and BSL4 viruses; (iii) facile characterization of aerosolization parameters; (iv) ability to adapt the system to other viral envelope proteins including those of newly discovered pathogens and mutant variants; (v) the ability to introduce viral sequences to develop nucleic acid amplification assays.

PubMed Disclaimer

Conflict of interest statement

Competing Interests The authors declare no competing interests.

Figures

Figure 1:
Figure 1:. Western blot analysis for presence of SARS-CoV-2 spike in VLP and inactivated SARS-CoV-2.
For this analysis, equivalent amounts of total protein were used.
Figure 2:
Figure 2:. Real-time quantitative fluorescent LAMP analysis to detect plasmid.
(a) Amplification plots of solutions containing 3.1 × 109, 3.1 × 107, 3.1 × 106, 3.1 × 105, 3.1 × 104, and 3.1 × 103 gene copies (left to right). The control experiment, which contains no template, is shown as closed circles. (b) Standard curves for the Cq values versus gene copy number. Plasmid pNL4–3.Luc.R-E-. was used for these experiments.
Figure 3:
Figure 3:. Temperature and sensitivity limits for detection by LAMP.
(a) LAMP colorimetric assay for different temperatures (no template control on the left and added plasmid on the right). (b) Colorimetric LAMP assay. (c) SYBR Green stained agarose gel of LAMP reaction products. M=Marker, 1=NTC, 2=50 copies, 3=25 copies, 4=12.5 copies, 5= 6.75 copies.
Figure 4:
Figure 4:. Real-time quantitative fluorescent Reverse-Transciption LAMP.
For these experiments, heat treatment corresponded to incubation of VLP at 95 °C for 10 minutes before analysis and detergent treatment corresponded to VLP dilution into a buffer containing 12.5 mM TCEP, 5 mM EDTA, and 0.002% Triton X100 at pH 8.0.
Figure 5:
Figure 5:. Detection of VLP by RT-LAMP.
(a) Colorimetric RT-LAMP assay. (b) SYBR Green stained agarose gel of LAMP reaction products. M=Marker, 1=NTC, 2=300 copies, 3=30 copies, 4=3 copies, 5= 0.3 copies.
Figure 6:
Figure 6:
Experimental setup for aerosolized VLP.
Figure 7:
Figure 7:. Detection of aerosolized VLP on a MCE filter.
(a) Colorimetric RT-LAMP assay. (b) SYBR Green stained agarose gel of LAMP reaction products. M=Marker, 1=NTC, 2=Filter Extract, 3=Filter Extract 1/10 dilution, 4=Filter Extract 1/100 dilution.

References

    1. Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, Zhong W, Hao P. 2020. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci 63:457–460. - PMC - PubMed
    1. Sun J, He WT, Wang L, Lai A, Ji X, Zhai X, Li G, Suchard MA, Tian J, Zhou J, Veit M, Su S. 2020. COVID-19: Epidemiology, evolution, and cross-disciplinary perspectives. Trends Mol Med 26:483–495. - PMC - PubMed
    1. Anderson RM, Fraser C, Ghani AC, Donnelly CA, Riley S, Ferguson NM, Leung GM, Lam TH, Hedley AJ. 2004. Epidemiology, transmission dynamics and control of SARS: the 2002–2003 epidemic. Philos Trans R Soc Lond B Biol Sci 359:1091–1105. - PMC - PubMed
    1. Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. 2020. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet 395:931–934. - PMC - PubMed
    1. Wang CC, Prather KA, Sznitman J, Jimenez JL, Lakdawala SS, Tufekci Z, Marr LC. 2021. Airborne transmission of respiratory viruses. Science 373:eabd9149. - PMC - PubMed

Publication types